These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29271135)

  • 1. [Hypophosphatasia].
    Winckert A; Vranken L; Boemer F; Courtois J; Cavalier E
    Rev Med Liege; 2017 Dec; 72(12):547-551. PubMed ID: 29271135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry.
    Högler W; Langman C; Gomes da Silva H; Fang S; Linglart A; Ozono K; Petryk A; Rockman-Greenberg C; Seefried L; Kishnani PS
    BMC Musculoskelet Disord; 2019 Feb; 20(1):80. PubMed ID: 30764793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy for hypophosphatasia].
    Ozono K
    Clin Calcium; 2007 Oct; 17(10):1600-6. PubMed ID: 17906415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
    Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations.
    Shapiro JR; Lewiecki EM
    J Bone Miner Res; 2017 Oct; 32(10):1977-1980. PubMed ID: 28731215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
    Whyte MP; Rockman-Greenberg C; Ozono K; Riese R; Moseley S; Melian A; Thompson DD; Bishop N; Hofmann C
    J Clin Endocrinol Metab; 2016 Jan; 101(1):334-42. PubMed ID: 26529632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophosphatasia: An overview For 2017.
    Whyte MP
    Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial.
    Kitaoka T; Tajima T; Nagasaki K; Kikuchi T; Yamamoto K; Michigami T; Okada S; Fujiwara I; Kokaji M; Mochizuki H; Ogata T; Tatebayashi K; Watanabe A; Yatsuga S; Kubota T; Ozono K
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):10-19. PubMed ID: 28374482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal and infantile hypophosphatasia: clinical features and treatment.
    Baujat G; Michot C; Le Quan Sang KH; Cormier-Daire V
    Arch Pediatr; 2017 May; 24(5S2):5S61-5S65. PubMed ID: 29405934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophosphatasia: an overview of the disease and its treatment.
    Bianchi ML
    Osteoporos Int; 2015 Dec; 26(12):2743-57. PubMed ID: 26245849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostics and treatment of hypophosphatasia].
    Hepp N; Frederiksen AL; Khosravi J; Jensen JB
    Ugeskr Laeger; 2018 Aug; 180(35):. PubMed ID: 30152322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Diagnostic Algorithm for Children with Low Alkaline Phosphatase Activities: Lessons Learned from Laboratory Screening for Hypophosphatasia.
    Saraff V; Narayanan VK; Lawson AJ; Shaw NJ; Preece MA; Högler W
    J Pediatr; 2016 May; 172():181-186.e1. PubMed ID: 26896157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophosphatasia.
    Linglart A; Biosse-Duplan M
    Curr Osteoporos Rep; 2016 Jun; 14(3):95-105. PubMed ID: 27084188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review.
    Szabo SM; Tomazos IC; Petryk A; Powell LC; Donato BMK; Zarate YA; Tiulpakov A; Martos-Moreno GÁ
    Orphanet J Rare Dis; 2019 Apr; 14(1):85. PubMed ID: 31023354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-replacement therapy in perinatal hypophosphatasia: Case report and review of the literature.
    Rougier H; Desrumaux A; Bouchon N; Wroblewski I; Pin I; Nugues F; Mornet E; Baujat G
    Arch Pediatr; 2018 Oct; 25(7):442-447. PubMed ID: 30249491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment.
    Bianchi ML; Bishop NJ; Guañabens N; Hofmann C; Jakob F; Roux C; Zillikens MC;
    Osteoporos Int; 2020 Aug; 31(8):1445-1460. PubMed ID: 32162014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.
    Schmidt T; Mussawy H; Rolvien T; Hawellek T; Hubert J; Rüther W; Amling M; Barvencik F
    Osteoporos Int; 2017 Sep; 28(9):2653-2662. PubMed ID: 28547134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypophosphatasia.
    Simon S; Resch H
    Wien Med Wochenschr; 2020 Apr; 170(5-6):112-115. PubMed ID: 32072352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypophosphatasia in children and adolescents: clinical features and treatment.
    Rothenbuhler A; Linglart A
    Arch Pediatr; 2017 May; 24(5S2):5S66-5S70. PubMed ID: 29405935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypophosphatasia : What is currently available for treatment?].
    Schmidt T; Amling M; Barvencik F
    Internist (Berl); 2016 Dec; 57(12):1145-1154. PubMed ID: 27796472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.